Lpl Financial LLC Kala Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.3 - $1.31 $5,255 - $22,949
-17,519 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.61 - $1.84 $652 - $1,966
1,069 Added 6.5%
17,519 $24,000
Q4 2021

Feb 14, 2022
SELL
$1.16 - $2.74 $1,160 - $2,740
-1,000 Reduced 5.73%
16,450 $20,000
Q3 2021

Nov 15, 2021
BUY
$2.62 - $5.43 $45,719 - $94,753
17,450 New
17,450 $46,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email